Empros Pharma AB is a biopharmaceutical company headquartered in Stockholm, Sweden. It is developing EMP16, an investigational oral fixed-dose combination of orlistat and…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Empros Pharma AB →Already a subscriber? Sign in
Xcout Intel tracks Empros Pharma AB continuously — this profile deepens as new filings, funding, people and hiring data arrive.